Form 8-K - Current report:
SEC Accession No. 0001193125-22-298474
Filing Date
2022-12-05
Accepted
2022-12-05 16:31:03
Documents
12
Period of Report
2022-11-28
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d415058d8k.htm   iXBRL 8-K 30927
  Complete submission text file 0001193125-22-298474.txt   161129

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA imra-20221128.xsd EX-101.SCH 2839
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20221128_lab.xml EX-101.LAB 19501
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20221128_pre.xml EX-101.PRE 12149
6 EXTRACTED XBRL INSTANCE DOCUMENT d415058d8k_htm.xml XML 3580
Mailing Address 1309 BEACON STREET SUITE 300 BROOKLINE MA 02446
Business Address 1309 BEACON STREET SUITE 300 BROOKLINE MA 02446 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39247 | Film No.: 221445382
SIC: 2834 Pharmaceutical Preparations